419 related articles for article (PubMed ID: 10386633)
1. Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: factors influencing local control and soft tissue complications.
Fujita M; Hirokawa Y; Kashiwado K; Akagi Y; Kashimoto K; Kiriu H; Matsuura K; Ito K
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):767-75. PubMed ID: 10386633
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors of local outcome for T1, T2 carcinomas of oral tongue treated by iridium 192 implantation.
Mazeron JJ; Crook JM; Marinello G; Walop W; Pierquin B
Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):281-5. PubMed ID: 2394607
[TBL] [Abstract][Full Text] [Related]
3. An analysis of mandibular bone complications in radiotherapy for T1 and T2 carcinoma of the oral tongue.
Fujita M; Hirokawa Y; Kashiwado K; Akagi Y; Kashimoto K; Kiriu H; Ohtani K; Wada T
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):333-9. PubMed ID: 8567334
[TBL] [Abstract][Full Text] [Related]
4. Postoperative brachytherapy alone and combined postoperative radiotherapy and brachytherapy boost for squamous cell carcinoma of the oral cavity, with positive or close margins.
Lapeyre M; Bollet MA; Racadot S; Geoffrois L; Kaminsky MC; Hoffstetter S; Dolivet G; Toussaint B; Luporsi E; Peiffert D
Head Neck; 2004 Mar; 26(3):216-23. PubMed ID: 14999796
[TBL] [Abstract][Full Text] [Related]
5. Primary radiotherapy in the treatment of stage I and II oral tongue cancers: importance of the proportion of therapy delivered with interstitial therapy.
Wendt CD; Peters LJ; Delclos L; Ang KK; Morrison WH; Maor MH; Robbins KT; Byers RM; Carlson LS; Oswald MJ
Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1287-92. PubMed ID: 2370178
[TBL] [Abstract][Full Text] [Related]
6. Interstitial high-dose-rate brachytherapy in the treatment of base of tongue carcinoma.
Takácsi-Nagy Z; Polgár C; Oberna F; Somogyi A; Major T; Remenár E; Fodor J; Kásler M; Németh G
Strahlenther Onkol; 2004 Dec; 180(12):768-75. PubMed ID: 15592696
[TBL] [Abstract][Full Text] [Related]
7. The study of tumoral, radiobiological, and general health factors that influence results and complications in a series of 448 oral tongue carcinomas treated exclusively by irradiation.
Pernot M; Malissard L; Hoffstetter S; Luporsi E; Peiffert D; Aletti P; Kozminski P; Bey P
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):673-9. PubMed ID: 8040012
[TBL] [Abstract][Full Text] [Related]
8. American Brachytherapy Society Task Group Report: Combined external beam irradiation and interstitial brachytherapy for base of tongue tumors and other head and neck sites in the era of new technologies.
Takácsi-Nagy Z; Martínez-Mongue R; Mazeron JJ; Anker CJ; Harrison LB
Brachytherapy; 2017; 16(1):44-58. PubMed ID: 27592129
[TBL] [Abstract][Full Text] [Related]
9. T1 and T2 squamous cell carcinomas of the floor of the mouth: results of brachytherapy mainly using 198Au grains.
Matsumoto S; Takeda M; Shibuya H; Suzuki S
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):833-41. PubMed ID: 8598360
[TBL] [Abstract][Full Text] [Related]
10. [Place of iridium 192 implantation in irradiation of T1-T2 squamous cell carcinoma of the velopharyngeal arch].
Mazeron JJ; Belkacemi Y; Simon JM; Le Péchoux C; Martin M; Haddad E; Piedbois P; Calitchi E; Strunski W; Peynègre R; Le Bourgeois JP; Pierquin B
Bull Cancer Radiother; 1996; 83(1):47-53. PubMed ID: 8679281
[TBL] [Abstract][Full Text] [Related]
11. Postoperative brachytherapy alone for T1-2 N0 squamous cell carcinomas of the oral tongue and floor of mouth with close or positive margins.
Lapeyre M; Hoffstetter S; Peiffert D; Guérif S; Maire F; Dolivet G; Toussaint B; Mundt A; Chassagne JF; Simon C; Bey P
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):37-42. PubMed ID: 10924969
[TBL] [Abstract][Full Text] [Related]
12. [Clinical results of N0 tongue cancer treated with interstitial brachytherapy and management of occult cervical node metastases].
Tsujino K; Oshitani T; Kushima T; Mieda C; Hirota S; Ogawa K; Maruta T; Ikeda Y; Ueda E; Suematsu T
Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Jun; 51(6):671-7. PubMed ID: 1886756
[TBL] [Abstract][Full Text] [Related]
13. Iridium 192 implantation of T1 and T2 carcinomas of the mobile tongue.
Mazeron JJ; Crook JM; Benck V; Marinello G; Martin M; Raynal M; Haddad E; Peynègre R; Le Bourgeois JP; Walop W
Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1369-76. PubMed ID: 2262360
[TBL] [Abstract][Full Text] [Related]
14. Iridium-192 brachytherapy in the management of 147 T2N0 oral tongue carcinomas treated with irradiation alone: comparison of two treatment techniques.
Pernot M; Malissard L; Aletti P; Hoffstetter S; Forçard JJ; Bey P
Radiother Oncol; 1992 Apr; 23(4):223-8. PubMed ID: 1609126
[TBL] [Abstract][Full Text] [Related]
15. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base.
Karakoyun-Celik O; Norris CM; Tishler R; Mahadevan A; Clark JR; Goldberg S; Devlin P; Busse PM
Head Neck; 2005 May; 27(5):353-61. PubMed ID: 15726587
[TBL] [Abstract][Full Text] [Related]
16. [Time, dose and volume factors in interstitial brachytherapy combined with external irradiation for oral tongue carcinoma].
Yorozu A
Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Apr; 56(5):303-10. PubMed ID: 8692656
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy of stage I and II carcinomas of the mobile tongue and/or floor of the mouth.
Bachaud JM; Delannes M; Allouache N; Benchalal M; Alzieu C; David JM; Serrano E; Daly-Schveitzer NJ
Radiother Oncol; 1994 Jun; 31(3):199-206. PubMed ID: 8066202
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes after external beam irradiation and brachytherapy boost for base-of-tongue cancers.
Gibbs IC; Le QT; Shah RD; Terris DJ; Fee WE; Goffinet DR
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):489-94. PubMed ID: 12957261
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant high-dose-rate brachytherapy after external beam radiotherapy in nasopharyngeal carcinoma.
Ozyar E; Yildz F; Akyol FH; Atahan IL
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):101-8. PubMed ID: 11777627
[TBL] [Abstract][Full Text] [Related]
20. Results of low- and high-dose-rate interstitial brachytherapy for T3 mobile tongue cancer.
Kakimoto N; Inoue T; Inoue T; Murakami S; Furukawa S; Yoshida K; Yoshioka Y; Yamazaki H; Tanaka E; Shimizutani K
Radiother Oncol; 2003 Aug; 68(2):123-8. PubMed ID: 12972306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
